Published in Oncotarget on April 18, 2017
Measuring inconsistency in meta-analyses. BMJ (2003) 128.20
Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA (2000) 55.37
Heterogeneity and statistical significance in meta-analysis: an empirical study of 125 meta-analyses. Stat Med (2000) 11.03
Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol (2013) 7.31
Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA (2003) 5.39
Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab (1997) 4.47
Impairment of high-density lipoprotein resistance to lipid peroxidation and adipose tissue inflammation in obesity complicated by obstructive sleep apnea. J Clin Endocrinol Metab (2014) 1.98
Interleukin-6 and tumor necrosis factor-alpha in patients with obstructive sleep apnea-hypopnea syndrome. Respiration (2004) 1.63
Obstructive sleep apnea syndrome affects liver histology and inflammatory cell activation in pediatric nonalcoholic fatty liver disease, regardless of obesity/insulin resistance. Am J Respir Crit Care Med (2014) 1.60
The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directions. Curr Dir Autoimmun (2010) 1.57
The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome. Cytokine (2004) 1.54
Predictors of elevated nuclear factor-kappaB-dependent genes in obstructive sleep apnea syndrome. Am J Respir Crit Care Med (2006) 1.50
Obstructive sleep apnea and biomarkers of inflammation in ischemic stroke. Acta Neurol Scand (2011) 1.48
TNF-alpha as a therapeutic target in inflammatory diseases, ischemia-reperfusion injury and trauma. Curr Med Chem (2009) 1.47
Elevated production of tumor necrosis factor-alpha by monocytes in patients with obstructive sleep apnea syndrome. Chest (2004) 1.44
Serum inflammatory markers in obstructive sleep apnea: a meta-analysis. J Clin Sleep Med (2013) 1.35
Inflammatory mediators in exhaled breath condensate of children with obstructive sleep apnea syndrome. Chest (2006) 1.31
Plasma cytokine levels in patients with obstructive sleep apnea syndrome: a preliminary study. J Sleep Res (2003) 1.25
Obstructive sleep apnea and inflammation. Prog Cardiovasc Dis (2009) 1.15
TNF-alpha gene polymorphism and TNF-alpha levels in obese Asian Indians with obstructive sleep apnea. Respir Med (2008) 1.07
TNF-α gene polymorphisms and excessive daytime sleepiness in pediatric obstructive sleep apnea. J Pediatr (2010) 1.06
Inflammatory measures in children with obstructive sleep apnoea. J Paediatr Child Health (2006) 1.05
Increased C-reactive protein and increased plasma interleukin-6 may synergistically affect the progression of coronary atherosclerosis in obstructive sleep apnea syndrome. Circulation (2003) 1.04
Inflammatory proteins in patients with obstructive sleep apnea with and without daytime sleepiness. Sleep Breath (2007) 1.00
The activation of the inflammatory cytokines in overweight patients with mild obstructive sleep apnoea. J Sleep Res (2009) 0.99
Inflammatory markers in middle-aged obese subjects: does obstructive sleep apnea syndrome play a role? Mediators Inflamm (2010) 0.98
CPAP decreases plasma levels of soluble tumour necrosis factor-alpha receptor 1 in obstructive sleep apnoea. Eur Respir J (2008) 0.97
Correlation between inflammatory markers of atherosclerosis and carotid intima-media thickness in Obstructive Sleep Apnea. Molecules (2014) 0.96
Experimental pain and opioid analgesia in volunteers at high risk for obstructive sleep apnea. PLoS One (2013) 0.96
TNF-α and temporal changes in sleep architecture in mice exposed to sleep fragmentation. PLoS One (2012) 0.96
Continuous positive airway pressure therapy improves hypoadiponectinemia in severe obese men with obstructive sleep apnea without changes in insulin resistance. Metab Syndr Relat Disord (2009) 0.93
Tumor necrosis factor-alpha expression in uvular tissues differs between snorers and apneic patients. Chest (2008) 0.93
Lower frequency of obstructive sleep apnea in spondyloarthritis patients taking TNF-inhibitors. J Clin Sleep Med (2012) 0.92
Production of inflammatory mediators by monocytes in patients with obstructive sleep apnea syndrome. Intern Med (2009) 0.92
Blood trace minerals concentrations and oxidative stress in patients with obstructive sleep apnea. J Nutr Health Aging (2013) 0.91
The change of interleukin-6 and tumor necrosis factor in patients with obstructive sleep apnea syndrome. J Tongji Med Univ (2000) 0.91
Comparison of serum adiponectin and tumor necrosis factor-alpha levels between patients with and without obstructive sleep apnea syndrome. Respiration (2008) 0.90
Inflammatory cytokines and childhood obstructive sleep apnoea. Ann Acad Med Singapore (2008) 0.89
Plasma ghrelin and pro-inflammatory markers in patients with obstructive sleep apnea and stable coronary heart disease. Med Sci Monit (2013) 0.88
Cytokine changes after surgical treatment of obstructive sleep apnoea syndrome. Eur Arch Otorhinolaryngol (2008) 0.87
Exhaled breath condensate cytokine level as a diagnostic tool for obstructive sleep apnea syndrome. Sleep Med (2008) 0.87
Influence of CPAP treatment on airway and systemic inflammation in OSAS patients. Sleep Breath (2012) 0.87
Obstructive sleep apnea, hypertension and cardiovascular diseases. J Hum Hypertens (2015) 0.87
Are biomarker levels a good follow-up tool for evaluating obstructive sleep apnea syndrome treatments? Respiration (2008) 0.85
Plasma levels of MCP-1 and adiponectin in obstructive sleep apnea syndrome. Arch Otolaryngol Head Neck Surg (2010) 0.85
Obstructive sleep apnoea syndrome is associated with enhanced sub-clinical inflammation and asymmetric dimethyl-arginine levels in hypertensives. J Hum Hypertens (2008) 0.84
Higher levels of plasma TNF-alpha and neuropeptide Y in hypertensive patients with obstructive sleep apnea syndrome. Clin Exp Hypertens (2010) 0.83
High levels of inflammation and insulin resistance in obstructive sleep apnea patients with hypertension. Inflammation (2012) 0.82
Airway inflammation in obstructive sleep apnea: is leptin the missing link? Respir Med (2008) 0.82
Lack of association between objectively assessed sleep disorders and inflammatory markers among kidney transplant recipients. Int Urol Nephrol (2011) 0.82
Effect of continuous positive airway pressure on soluble CD40 ligand in patients with obstructive sleep apnea syndrome. Chest (2006) 0.82
Increased systemic inflammation overnight correlates with insulin resistance among children evaluated for obstructive sleep apnea. Sleep Breath (2011) 0.81
Insulin resistance and adipose-derived hormones in young men with untreated obstructive sleep apnea. Sleep Breath (2012) 0.81
Inhibiting tumor necrosis factor-alpha diminishes desmoplasia and inflammation to overcome chemoresistance in pancreatic ductal adenocarcinoma. Oncotarget (2016) 0.80
Tumour necrosis factor-α/interleukin-10 ratio in patients with obstructive sleep apnoea hypopnoea syndrome. J Laryngol Otol (2014) 0.78
Is there an effect of obstructive sleep apnea syndrome on oxidative stress and inflammatory parameters in patients with craniofacial anomalies? J Craniofac Surg (2013) 0.78
Reduced systemic levels of IL-10 are associated with the severity of obstructive sleep apnea and insulin resistance in morbidly obese humans. Mediators Inflamm (2015) 0.77
Increased inflammatory activity in nonobese patients with coronary artery disease and obstructive sleep apnea. Sleep (2015) 0.77
Effects of nasal CPAP on exhaled SIRT1 and tumor necrosis factor-α in patients with obstructive sleep apnea. Respir Physiol Neurobiol (2016) 0.76
The effect of the severity of obstructive sleep apnea syndrome on telomere length. Oncotarget (2016) 0.76
Crucial factors of the inflammatory microenvironment (IL-1β/TNF-α/TIMP-1) promote the maintenance of the malignant hemopoietic clone of myelofibrosis: an in vitro study. Oncotarget (2016) 0.76
Ataxia-telangiectasia mutated activation mediates tumor necrosis factor-alpha induced MMP-13 up-regulation and metastasis in lung cancer cells. Oncotarget (2016) 0.76
Obstructive sleep apnea, excessive daytime sleepiness, and morning plasma TNF-α levels in Greek children. Sleep (2013) 0.76
Relationship between zinc finger protein 36 (ZFP36) gene polymorphisms and obstructive sleep apnea. Genet Mol Res (2015) 0.76
Changes in ghrelin, leptin and pro-inflammatory cytokines after therapy in Obstructive Sleep Apnea Syndrome (OSAS) patients. Otolaryngol Pol (2015) 0.76
Chronic obstructive sleep apnea accelerates pulmonary remodeling via TGF-β/miR-185/CoLA1 signaling in a canine model. Oncotarget (2016) 0.76
Obstructive Sleep Apnea in Acute Stroke: A Role for Systemic Inflammation. Stroke (2016) 0.76